Further studies should aim to elucidate the mechanistic role of ApoJ in muscle cell differentiation, oxidative damage response, and muscle-liver communication, as these pathways may reveal new therapeutic targets or biomarkers for sarcopenia. This evidence concerns the gene CLU and sarcopenia.